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Decreasing trends, and geographical
variation in outpatient antibiotic use: a
population-based study in Central Denmark
Pia Kjær Kristensen1,2* , Søren Paaske Johnsen3 and Reimar Wernich Thomsen1
Abstract
Background: Antimicrobial overuse and misuse of broad-spectrum antibiotics increases the risk for antimicrobial
resistance. Investigating unwarranted variation in antibiotic prescription has therefore gained global priority.
Methods: We examined recent time trends in the utilization of narrow- and broad-spectrum antibiotics as well as
the variation in antibiotic use by sex, age, and municipality of residence. Complete individual-level data on all
redeemed out-of hospital prescriptions for antibiotics in the entire adult population of Central Denmark (1.3 million
inhabitants) was obtained for the period 2006–2015.
Results: Following an initial increase of 2% between 2006 and 2011, the overall rate of redeemed prescriptions for
antibiotics per 1000 person years declined by 17% between 2011 and 2015. Among persons aged over 65 years, the
decline in use began later (from 2013) and was less pronounced. Antibiotic use in 2015 remained substantially
higher among females (289/1000 person-years) vs. males (182/1000 person-years) and among the very old (520/
1000 person-years in >85y old) vs. middle-aged (204/1000 person-years in 45-65y old). A decreasing trend in
antibiotic use over time was observed in all municipalities, mainly due to a decrease in narrow-spectrum antibiotics.
However, a striking and unexplained 1.6-fold geographical variation in antibiotic use, including tetracyclines,
macrolides and fluoroquinolones remained in 2015. Of concern, among females aged ≥65 years and males aged
≥85 years, a continuous increasing trend in broad-spectrum antibiotic use was observed.
Conclusions: Antibiotic use has decreased almost 20% in Central Denmark after 2011, possibly related to a
nationwide antibiotic stewardship program in Denmark. However, substantial geographical variation in antibiotic
prescription remains and the use of broad-spectrum antibiotics has increased in adults of older age. Continuous
focus on avoiding unnecessary use of broad-spectrum antibiotics is requested.
Keywords: Antibiotics, Drug utilization, Outpatient prescriptions, Trends
Background
Healthcare systems worldwide face the threat of antibiotic
resistance, rendering patients at risk of ineffective treatment
and increasing healthcare costs. Antimicrobial overuse and
misuse is an important risk factor for antimicrobial resistance
and appropriate antibiotic prescribing behavior is conse-
quently important to ensure patient safety and quality of care
[1–4]. However, real world antibiotic prescribing behavior
does not always comply with clinical guidelines recommen-
dations [5] and investigating unwarranted variation in anti-
biotic prescription has therefore gained priority in both the
European Union and the United States [6–11].
Studies on antibiotic utilization in the European countries
have shown increasing overall antibiotic prescribing rates
during the early 2000s, while the prescribing rates apparently
decreased in the United States from 2006 to 2010 [7, 8, 11].
Newer data on outpatient antibiotic use are scarce. Further-
more, studies have shown up to four-fold variation in anti-
biotic use within the European Union [6, 8, 10, 11], both
between countries and between geographical regions in indi-
vidual countries [12–15]. Striking variation has also been
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observed in the utilization of specific antibiotics, including
penicillins with extended spectrum, macrolides and quino-
lones [11]. The increased use of these subgroups is particular
problematic as they are associated with growing resistance
problem [16, 17]. Although the Danish prescribing rates for
antibiotics are low compared with the US and many other
European countries [6], antibiotic use in Denmark increased
from 1997 to 2007 [8]. Furthermore, a remarkably high use
was recently observed among people aged over 65 years in
Denmark compared to the Italy, Germany, the Netherlands
and United Kingdom [8].
In 2012, after the total consumption of antibiotics in
humans had steadily increased throughout the 2000s in
Denmark, the national Danish Health Authorities published
“Guidelines on prescribing antibiotics for physicians and
others in Denmark” [18]. The nationwide initiative focused
on reducing unnecessary antibiotic use including the use of
critically important antibiotics such as carbapenems, fluoro-
quinolones and cephalosporins in an outpatient setting [19].
Moreover, a targeted campaign towards the population called
“antibiotics or not” with information on adverse effects from
antibiotics was initiated. We hypothesize that the national
stewardship programs may have contributed to a more ra-
tional use of antibiotics in our region, Central Denmark.
Correspondingly, annual reports from the Danish Ministry
of Health (Statens Serum Institut) have indicated a recent
decline in the overall use of antibiotics in primary health care
in Denmark from 2011 to 2017, however, these reports do
not include detailed analyses regarding patient characteristics
and geographics [20]. It is therefore unknown whether the
national stewardship programs also contributed to appropri-
ate antibiotic use within different groups of patients and
within different municipalities in Central Denmark.
Unlike most countries, the availability of population-based
community pharmacy prescription data at the individual per-
son level in Denmark makes it possible to investigate not only
time trends in overall antibiotic utilization, but also use of in-
dividual antibiotic prescriptions, including their dose and
treatment duration, by patient sex, age group, and geograph-
ical residence. We therefore conducted a population-based
drug utilization study to examine changes in antibiotic pre-
scribing within the last decade including particular types of
antibiotics in relation to age, sex and municipality.
Methods
We conducted a population-based cohort study among all
inhabitants above 15 years living in Central Denmark Region
from 2006 to 2015. The Central Denmark Region is one of
five regions in Denmark, which covers both urban and rural
areas. The region has 1.3 million inhabitants, corresponding
to 23% of the Danish population [21]. The population of the
region is representative for the entire country with respect to
healthcare usage, medication use, demographic, as well as so-
cioeconomic characteristics [22]. The Danish National
Health Service provides universal healthcare financed by tax,
which guarantee unfettered access to healthcare services and
partial reimbursement for prescribed drugs. All Danish citi-
zens are provided with a unique personal registry number,
which enable unambiguous linkage of all registries at the in-
dividual level.
Data sources
The Danish Civil Registration System was used to identify
cohort of inhabitants above 15 years living in Central
Denmark Region. The Danish Civil Registration System con-
tains electronic records on vital status (date of birth, emigra-
tion and death), and place of residence for the entire Danish
population since 1968, which allow us to keep track of the
inhabitants included. The registry is updated daily [23].
The Danish National Health Service Prescription Database
was used to obtain data on antibiotic use. The database con-
tains complete data on all reimbursed prescription medica-
tions dispensed from community pharmacies [24]. The
drugs in the Danish National Health Service Prescription
Database are coded according to the Anatomical Thera-
peutic Chemical (ATC) classification system. The database
contains information on prescriptions and dispensing includ-
ing Defined Daily Doses (DDD) (WHO, version 2011) [25].
Antibiotic utilization
Use of antibiotics was defined, as antibiotic for systemic use
including all drugs within Anatomical Therapeutic Chemical
(ATC)-group J01. Data was aggregated at the level of active
chemical substance using ATC classification. We dived the
use of antibiotics into tetracyclines (J01A), amphenicols
(J01B), beta-lactam antibacterial penicillins (J01C), cephalo-
sporins (J01D), trimethoprim and sulphonamides (J01E),
macrolides and lincosamides (J01F), aminoglycosides (J01G),
quinolones (J01M) and other antibacterials (J01X).
Statistical analysis
We calculated the annual prescribing rates of antibiotic use
per 1000 person-years calculated as the number of inhabi-
tants who filled at least one antibiotic prescription divided by
the total cumulated person time in the observation year and
multiplied by 1000. We presented the prescribing rates of
antibiotic use stratified for sex and age group (15–40 years,
40–65 years, 65–85 years, > 85 years). We also estimated the
volume of antibiotic use as Defined Daily Dose (DDD) per
1000 inhabitants per day as overall and stratified for sex and
age. Furthermore, we investigated temporal trends 2006–
2016 in both prescribing rates and volume of antibiotic use.
To investigate intra-regional differences in the use of anti-
biotics, we estimated sex and age standardized prescribing
rates of antibiotic use, and age and sex standardized vol-
ume of antibiotic use (DDD per 1000 inhabitants per day)
by each municipality in the region stratified by year. The
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standardization was performed in relation to data from
the entire Central Denmark Region in 2006.
We repeated the analyses for narrow- and
broad-spectrum antibiotics separately. Narrow spectrum
antibiotics were defined as beta-lactamase sensitive peni-
cillins (J01 CE), beta-lactamase resistant penicillins
(J01CF), first-generation cephalosporins (J01DB), and
macrolides (J01FA01). Broad-spectrum antibiotics in-
cluded combinations of penicillins including beta-lacta-
mase inhibitors (J01CR), penicillins with extended
spectrum (J01CA), second-generation cephalosporins
(J01 DC), third-generation cephalosporins (J01DD),
macrolides, lincosamides and streptogramins (J01F). We
also investigated the use of each of the following classes
of antibiotics: Tetracyclines (J01AA), penicillins with ex-
tended spectrum (J01CA), beta-lactamase sensitive peni-
cillins (J01 CE), beta-lactamase resistant penicillins
(J01CF), combinations of penicillins including
beta-lactamase inhibitors (J01CR), trimethoprim and
sulphonamides (J01E), macrolides, lincosamides and
streptogramins (J01F), fluoroquinolones (J01MA),
metronidazol (G01AF01, J01XD01, P01AB01) and other
antibacterials (J01X). We calculated both antibiotic pre-
scribing rates and volume of antibiotic use (DDD per
1000 inhabitants per day) of the subgroups of
antibiotics.
Additionally, we examined the subgroups of antibiotics
within the municipalities and calculated the mean dur-
ation of antibiotic use per prescription by adding the
total days of antibiotic exposure (DDD*packsize) divided
by the total number of prescriptions retrieved for the
calendar year 2015.
All analyses were performed using SAS version 9.4.
Results
The overall age and sex standardized prescribing rates of
antibiotic use in Central Denmark Region increased
slightly from 285/1000 person-years in 2006 to 290/1000
person-years in 2011 after which the antibiotic prescrib-
ing rates decreased to 236/1000 person-years in 2015.
Figure 1 shows the overall prescribing rates of antibiotic
use per 1000 person-years from 2006 to 2015 and strati-
fied for females and males. The decrease from year 2011
and forward was found among both sexes (Fig. 1). The
lower overall use of antibiotics over time appeared pri-
marily to be related to a decreasing use in the youngest
age groups (Fig. 2). In contrast, the prescribing rates of
antibiotic use among adults above 85 years increased
from 510/1000 person-years in 2006 to 541/1000
person-years in 2013. From 2013 through 2015 there
was a small decrease in prescribing rates towards 520/
1000 person-years for adults above 85 years. However, a
more than 2-fold variation between the youngest and
oldest age groups remained in the calendar year 2015
(Fig. 2). The decrease in antibiotic use over time was
present in all municipalities in the region, but remark-
able geographical variation in sex and age standardized
antibiotic utilization was still seen in the municipalities,
especially in the period before 2011 (Fig. 3).
When estimating the volume of antibiotic, we saw a
similar picture with decrease in overall volume of antibi-
otics from 5589 DDD/1000 persons in 2011 to 4709
DDD/1000 persons in 2015 (Additional file 1: Table S2).
The decrease in antibiotic volume was seen for both fe-
males and males (Additional file 1: Table S2). There was
an 8-fold variation in antibiotic volume used across age
groups, from 2741 DDD/1000 person-years for the
Fig. 1 Prescribing rates of antibiotic use per 1000 person-years 2006 to 2015, overall and stratified by sex
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youngest age group to 22,332 DDD/1000 person-years
for adults above 85 years (Additional file 1: Table S2).
The steady decrease in prescribing rates of overall anti-
biotic use since 2011 was mainly due to a decrease in the
prescribing rates of narrow-spectrum antibiotic use
(Fig. 4). The decrease in prescribing rates of
narrow-spectrum antibiotics started in 2007, and was seen
for both females and males as well as for all age groups,
but particularly for females aged 15–39 years (Fig. 5). The
prescribing rates of broad-spectrum antibiotic increased
from 109/1000 persons in 2006 to 138/1000 persons in
2011, after which a small decrease to 125/1000 persons in
2015 was observed. However, the prescribing rates for
broad-spectrum antibiotic increased for females above 65
years and males above 85 years (Fig. 5). The small de-
crease in overall broad-spectrum antibiotic from 2011 was
apparently confined to males and females below 40 years.
In addition, the prescribing rates of broad-spectrum anti-
biotic use in 2015 had become higher than that of
narrow-spectrum antibiotics (Fig. 4). A similar picture was
seen for the volume of narrow- and broad-spectrum anti-
biotics (Additional file 1: Table S3).
Fig. 2 Prescribing rates of antibiotic use per 1000 person-years 2006 to 2015, stratified by age group
Fig. 3 Age and sex standardized prescribing rates of antibiotic use per 1000 person-years by municipalities. Age and sex standardized prevalence
of antibiotic use per 1000 person-years 2006 to 2015: variation according to the municipalities in Central Denmark Region
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The most frequently used antibiotics through all years
were beta-lactamase sensitive penicillins (J01 CE), and peni-
cillins with extended spectrum (J01CA) (Fig. 6). The use of
penicillins with extended spectrum (J01CA), sulfonamides
and trimethoprim (J01E), fluoroquinolones (J01MA), as well
as other anti-bacterials (J01X) was rather stable through the
years across sex and age groups (Additional file 1: Figure S7).
Use of sulfonamides and trimethoprim (J01E) was most fre-
quent among adults above 85 years (123/1000 person-years)
while the prescribing rates accounted for less than 41/1000
person-years in other age groups. A decrease in prescribing
rates was observed for beta lactamase sensitive penicillins
(J01 CE) for all patient groups. A decrease was also seen
from 2011 to 2015, for the use of macrolides, lincosamides
and streptogramins (J01F). The prescribing rates of
beta-lactamase resistant penicillins (J01CF) was stable
until 2014 after which a decrease was observed among all
groups. A small increase was seen for use of metronidazol
(G01AF01, J01XD01, P01AB01), especially for females,
whereas a notably large increase in prescribing rates was
found for combinations of penicillins including beta-lacta-
mase inhibitors (J01CR). This increase was seen for both
females and males and within all age groups throughout
the years, but especially noted for persons above 65 years
(Additional file 1: Figure S7). Similar trends were seen for
the volume of subgroup antibiotics used (Additional file 1:
Figure S8).
Differences in the age and sex standardized volume of
different antibiotics were also observed between the mu-
nicipalities (Additional file 1: Table S4). For instance,
tetracycline (J01AA) use varied up to 4 times between
different municipalities. In addition, use of macrolides
(J01F) and fluoroquinolones (J01MA) was twice as high
in some municipalities versus others. There was no
major variation between municipalities in the use of
combinations of penicillins including beta-lactamase in-
hibitors (J01CR).
Mean duration of antibiotic treatment in days varied
between the antibiotic subgroups as expected, but also
between age groups (Table 1). Adults over 85 years had
11 days and 14 days longer duration of antibiotic treat-
ment with tetracyclines (J01AA) and sulfonamides/tri-
methoprim (J01E) respectively, compared to the
youngest age group. In contrast, the youngest age group
had 23 days longer duration of treatment with flourqui-
nolones (J01MA) compared to the oldest individuals.
For combinations of penicillins including beta-lactamase
inhibitors (J01CR), a 2 day longer duration was observed
for people below 65 years compared to people above 85
years. No variation in mean duration of antibiotic treat-
ment was observed between females and males.
Discussion
Prescribing rates of antibiotics have decreased consider-
ably in Central Denmark after 2011 after an initial slight
increase between 2006 and 2011. The decline in use
began later (from 2013) and was less pronounced in the
older age groups, whereas a similar decline was seen for
both sexes. However, the pattern of much higher anti-
biotic use in females versus males, and among older ver-
sus younger people has remained also in the most recent
years. The overall use of narrow-spectrum antibiotics
decreased substantially over the years, while the pre-
scribing rates of broad-spectrum antibiotic use first de-
clined from 2011 onwards. Of concern, among females
aged ≥65 years and males aged ≥85 years a continuously
Fig. 4 Prescribing rates of broad- and narrow-spectrum antibiotic use per 1000 person-years 2006 to 2015
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increasing trend in broad-spectrum antibiotic use was
observed from 2006 to 2015, primarily related to in-
creasing use of combinations of penicillins including
beta-lactamase inhibitors. There was a clear decline in
antibiotic use in all municipalities over time, although
striking geographical differences remained in antibiotic
use in 2015 that were not explained by age and sex
differences.
Comparison with other studies
Our results regarding the notably high antibiotic use
among older persons match those observed in earlier
studies from Denmark and United States, [8, 26, 27].
Community physicians may tend to treat older persons
more aggressively with antibiotics and at a lower thresh-
old, due to multiple comorbid conditions that may in-
crease risk of adverse outcomes from untreated
infections in older individuals. On the other hand, a firm
medical indication for antibiotics should preferably be
present in older persons before treatment, due to in-
creased risk of side effects of antibiotics in older people
including Clostridium difficile colitis, interactions with
other medications in those with polypharmacy, or risk of
treatment-induced cognitive disturbances [28–30].
Fig. 5 Prescribing rates of broad- and narrow-spectrum antibiotic use per 1000 person-years by sex and age group
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The overall prescribing rates of antibiotic use were
relatively stable from 2006 to 2011, however when we
examined prescribing rates according to narrow- and
broad spectrum antibiotics a different picture was seen
(Fig. 4), as the prescribing rates of narrow-spectrum an-
tibiotics decreased while the rates of broad-spectrum
antibiotics increased at the same time. This is in accord-
ance with a previous Dutch study [12], which argue that
some doctors may have used broad-spectrum antibiotics
to replace narrow-spectrum antibiotics. In contrast to the
Dutch study, the use of broad-spectrum antibiotics de-
creased from 2011 to 2015 in our population. This could be
Fig. 6 Prescribing rates of antibiotic subgroup use per 1000 person-years 2006 to 2015
Table 1 Mean duration of antibiotic treatment in days according to sex and age groups in 2015
Overall Females Males
ATC codes Antibiotic group 15–
39
40–
64
65–
84
+
85
Overall 15–
39
40–
64
65–
84
+
85
Overall 15–
39
40–
64
65–
84
+
85
Overall
J01, G01AF01,
P01AB01, J04A
Overall 9.4 11.1 12.8 14.3 11.5 9.1 10.7 12.5 14.5 11.1 9.9 11.7 13.2 14.0 12.0
J01AA Tetracyclines 31.0 31.5 32.1 47.9 31.5 29.4 31.1 32.2 41.5 30.4 34.5 31.9 32.0 68.8 33.0
J01CA Penicillins with extended
spectrum
10.6 12.1 13.1 13.3 12.2 10.3 11.7 12.8 13.3 11.8 13.1 13.5 13.6 13.3 13.5
J01 CE Beta-lactamase sensitive penicillins 9.6 9.8 10.2 10.3 9.9 9.6 9.7 10.1 10.4 9.8 9.7 10.0 10.3 10.3 10.0
J01CF Beta-lactamase resistant penicillins 11.1 12.1 13.4 13.6 12.2 11.0 11.6 12.8 13.8 11.9 11.2 12.5 13.8 13.2 12.5
J01CR Combinations of penicillins, incl.
Beta-lactamase inhibitors
17.1 17.0 15.7 15.3 16.2 17.5 17.0 15.5 15.4 16.2 16.6 17.0 15.9 15.2 16.2
J01E Trimethoprim and sulphonamides 3.7 7.9 13.1 16.9 11.6 3.4 6.6 12.4 16.9 10.6 11.7 14.3 14.5 17.0 15.0
J01F Macrolides, lincosamides and
streptogramins
7.0 9.9 10.6 9.9 9.1 7.1 9.9 10.6 9.8 9.1 6.9 10.0 10.6 10.1 9.0
J01MA Fluoroquinolones 30.1 14.3 12.0 9.9 14.3 27.3 12.6 13.1 7.4 14.0 34.0 16.3 11.3 13.0 14.5
G01AF01,
J01XD01,
P01AB01
Metronidazol 4.9 5.5 6.0 6.2 5.4 4.8 5.4 5.8 6.1 5.2 5.5 5.8 6.2 6.3 5.9
Other J01 codes Other antibacterials 18.2 18.0 18.3 19.6 18.5 16.4 16.8 17.5 19.5 17.7 27.2 21.9 20.0 20.0 20.7
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related to a national antibiotic campaign from 2013 to 2015,
which focused on a more prudent choice of antimicrobials
when antibiotics is necessary emphasizing the importance of
using older narrow spectrum drugs including beta-lactamase
sensitive penicillins as first choice. However, still the de-
crease in broad-spectrum antibiotics was much lower than
that for narrow-spectrum antibiotics, primarily related to
the large increase in use of combinations of penicillins in-
cluding beta-lactamase inhibitors. In our latest study year,
we therefore observed that for the first time in Denmark,
prescribing of broad-spectrum antibiotics surpassed pre-
scribing of narrow-spectrum antibiotics.
The increase in use of broader spectrum antibiotics is
worrying as their use is related to resistance and adverse
drug events including gastrointestinal disturbances, sec-
ondary infections (including yeast and C difficile infec-
tions), nephrotoxicity, neurological or psychiatric effects,
sensory or motor disturbances, and allergic reactions [31].
Occurrence of such antibiotic-associated adverse events is
a threat to patient safety and costly for society [32].
Within the broad-spectrum antibiotics, a large increase
was observed for the combination penicillins with
beta-lactamase inhibitors, in particular among older
people. One could speculate that this may be related to
changes in regional and national recommendations for
treatment of moderate exacerbations in patients with
chronic obstructive pulmonary disease (COPD) in 2007,
where amoxicillin with clavulanic acid became a first line
drug in Denmark instead of narrow-spectrum penicillins
[33]. Denmark has one of the highest prevalence of COPD
worldwide [34], and patients with COPD and respiratory
infections are primarily seen at general practitioners. The
experienced effectiveness of amoxicillin with clavulanic
acid likely has made this antibiotic popular in all
middle-aged and older adults with respiratory infections,
of whom many have comorbidities, not only in COPD pa-
tients. A new review has found that clinicians’ fear of com-
plications from infections may be a reason for prescribing
broader spectrum agents than necessary [31].
Strengths and limitations
A major strength of this study is the use of complete
individual-level prescription drugs bought at monopo-
lized community pharmacies. All antimicrobial agents in
Denmark can be bought as prescription medication only
and redeemed prescriptions will therefore be a truthful
reflection of the actual utilization out of hospitals. Our
study also has some limitations. The study was restricted
to Central Denmark Region, but the homogeneity of the
Danish Healthcare System makes it likely that our re-
sults can be generalized to the four other regions in
Denmark [22]. Moreover, we were not able to directly
link the use of antibiotic agents to potential underlying
diagnoses in the study population. It is a limitation that
we in this drug utilization study are not able to make
firm conclusions about the potential causality between
the national stewardship program and the changes over
time in antibiotic use. It would in this context also be
relevant to examine the possible impact of changing
prescription behavior on the antibiotic resistance.
Unfortunately, we did not have the possibility to
analyse the occurrence of individual level antibiotic
resistance among people with recent antibiotic ex-
posure. However, the national stewardship program
was the most important specific intervention focused
on utilization of antibiotics in the Danish healthcare
system during the study period. No substantial
changes in the overall antibiotic resistance rates were
reported in this period by the Danish Ministry of
Health (Statens Serum Institut), which also supports
the hypothesis that the stewardship may be an im-
portant factor in the changing pattern of antibiotic
use. In addition, the Danish healthcare system has
otherwise been quite homogeneous and stable
throughout the period and no major demographic
changes occurred in the population except for some
ageing, which we accounted for in the analyses.
Perspective
Our data show that there is room for improvement
in antibiotic prescribing. The decrease in overall
antibiotic use mainly stems from a decrease in
narrow-spectrum antibiotics, which in general
should be the preferred antibiotics due to lower risk
of transmissible resistance development in bacteria.
The very large increase observed for use of combi-
nations of penicillins with beta-lactamase inhibitors
is worrying and tailored interventions for reducing
the use is needed. Furthermore, there remains huge
variation between Danish municipalities in the use
of critical antibiotics including tetracyclines, macro-
lides and fluoroquinolones. The fast trends in use
of individual antibiotics and the huge variation be-
tween Danish municipalities may suggest that the
use of antibiotics could be moved by safety con-
cerns or market factors including pricing, availabil-
ity and advertising rather than current guidelines
[35, 36]. Increased focus on avoiding unnecessary
use of combinations of penicillins with beta-lacta-
mase inhibitors, tetracyclines, macrolides and fluor-
oquinolones may be required in Denmark.
Conclusions
This study provides evidence for substantially decreasing
prescribing rates for antibiotics in Central Denmark after
2011. At the same time, the use of broad-spectrum anti-
biotics has increased and now for the first time surpasses
the use of narrow-spectrum antibiotics in Denmark.
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Additional file
Additional file 1: Table S2. shows volume of antibiotics DDD per 1000
person-years from 2006 to 2015 according to sex and age groups. Table
S3 shows volume of narrow- and broad-spectrum antibiotics DDD per
1000 person-years from 2006 to 2015, stratified by sex and age group
and Table S4 shows age and sex standardized volume of subgroup of
antibiotics, stratified by the municipalities in Central Denmark Region in
2015. Furthermore the file contains Figures S7 and S8, which shows pre-
scribing rates and volume of antibiotic per 1000 person-years from 2006
to 2015, stratified by sex and age group. (DOCX 1211 kb)
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